Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Shatila, Ahmed Osman
29  Ergebnisse:
Personensuche X
?
1

Disease modifying treatment guidelines for multiple scleros..:

Jacob, Anu ; Shatila, Ahmed Osman ; Inshasi, Jihad...
Multiple Sclerosis and Related Disorders.  88 (2024)  - p. 105703 , 2024
Link: https://doi.org/10.1016/..
 
?
2

A Case of Alopecia Areata Following Alemtuzumab in a Patien..:

Aljaberi, Kholoud Mohamed ; Chirakkara, Sudhir Kumar Palat ; Shatila, Ahmed Osman
Multiple Sclerosis and Related Disorders.  80 (2023)  - p. 105332 , 2023
Link: https://doi.org/10.1016/..
 
?
3

First Three NMOSD Case Series Started on IV Ravulizumab in ..:

Salih, Nihal Mohamedelmustafa Abdelrahman ; Chirakkara, Sudhir Kumar Palat ; Shatila, Ahmed Osman
Multiple Sclerosis and Related Disorders.  80 (2023)  - p. 105256 , 2023
Link: https://doi.org/10.1016/..
 
?
4

The Use of Ocrelizumab in Pediatric Multiple Sclerosis Pati..:

Atieh, Mutaz Iyad ; Riachi, Naji Joseph ; Kumar, Palat Chirakkara.
Multiple Sclerosis and Related Disorders.  71 (2023)  - p. 104280 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Colitis Due to Anti-B Cell Therapy: A Clinical Reality:

Aljaberi, Kholoud Mohamed ; Kumar, Sudhir Palat Chirakkara ; Shatila, Ahmed Osman.
Multiple Sclerosis and Related Disorders.  80 (2023)  - p. 105304 , 2023
Link: https://doi.org/10.1016/..
 
?
6

A Case of Myasthenia Gravis Treated with Ocrelizumab:

Aljaberi, Kholoud Mohamed ; Mandalawi, Ahmed Naseer ; Chirakkara, Sudhir Kumar Palat.
Multiple Sclerosis and Related Disorders.  80 (2023)  - p. 105324 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Position of Cladribine Tablets in the Management of Relapsi..:

Inshasi, Jihad S. ; Alfahad, Sarmed ; Alsaadi, Taoufik...
Neurology and Therapy.  10 (2021)  2 - p. 435-454 , 2021
Link: https://doi.org/10.1007/..
 
?
8

The use of alemtuzumab in patients with relapsing-remitting..:

Alroughani, Raed ; Van Wijmeersch, Bart ; Al Khaboori, Jabber...
Therapeutic Advances in Neurological Disorders.  13 (2020)  - p. 175628642095411 , 2020
Link: https://doi.org/10.1177/..
 
?
9

High-efficacy Therapies for relapsing-remitting Multiple Sc..:

Inshasi, Jihad Said ; Almadani, Abubaker ; Fahad, Sarmad Al...
Neurodegenerative Disease Management.  10 (2020)  4 - p. 257-266 , 2020
Link: https://doi.org/10.2217/..
 
?
10

The use of alemtuzumab in patients with relapsing-remitting..:

Alroughani, Raed ; Van Wijmeersch, Bart ; Al Khaboori, Jabber...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498833/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
11

The use of alemtuzumab in patients with relapsing-remitting..:

Alroughani, Raed ; VAN WIJMEERSCH, Bart ; Al Khaboori, Jabber...
Therapeutic Advances in Neurological Disorders, 13 (Art N° 1756286420954119).  , 2020
Link: http://hdl.handle.net/19..
 
?
12

The use of alemtuzumab in patients with relapsing-remitting..:

Raed Alroughani ; Bart Van Wijmeersch ; Jabber Al Khaboori...
https://doi.org/10.1177/1756286420954119.  , 2020
Link: https://doi.org/10.1177/..
 
?
13

An Overview of High-Efficacy Drugs for Multiple Sclerosis: ..:

Raed Alroughani ; Jihad Said Inshasi ; Dirk Deleu...
http://link.springer.com/article/10.1007/s40120-019-0129-0.  , 2019
Link: https://doi.org/10.1007/..
 
?
14

Position of Cladribine Tablets in the Management of Relapsi..:

Adis journals on behalf of (9646730) ; Jihad S. Inshasi (10305055) ; Sarmed Alfahad (10305057)...
https://figshare.com/articles/figure/Position_of_Cladribine_Tablets_in_the_Management_of_Relapsing-Remitting_Multiple_Sclerosis_An_Expert_Narrative_Review_From_the_United_Arab_Emirates/14217224.  , 2021
Link: https://doi.org/10.6084/..
 
?
15

Expert opinion on clinical experience with subcutaneous int..:

Bohlega, Saeed ; Alroughani, Raed ; Alkhawajah, Mona...
Neurology and Clinical Neuroscience.  7 (2019)  5 - p. 260-266 , 2019
Link: https://doi.org/10.1111/..
 
1-15